Literature DB >> 27072751

Successful treatment of areolar Fox-Fordyce disease with surgical excision and 1550-nm fractionated erbium glass laser.

Hyun H Han1, Jun Y Lee2, Jong W Rhie3.   

Abstract

Fox-Fordyce disease (FFD) is a rare chronic disorder characterised by persistent inflammation because of the obstruction of apocrine sweat glands, which is a key factor of pathogenesis. The treatment of FFD is known to be difficult, and the modalities of treatment have not yet been widely studied. We report the successful treatment of a case of bilateral areolar FFD by a combination of surgical excision and 1550-nm fractionated erbium glass laser in an 18-year-old woman. The patient presented with a bilateral areolar eruption of multiple, severely pruritic, 3-4 mm skin- to grey-coloured folliculocentric dome-shaped papules. The initial treatment plan was for bilateral surgical excision of the larger and more highly elevated papules via circumferential dermal excision, which was intended to maintain the areolar contour and minimise distortion. A 1550-nm fractional erbium glass laser was then used to control the remnant lesions. The patient was recurrence-free at 14 months after the final laser treatment, and she was fully satisfied with the treatment results.
© 2016 Medicalhelplines.com Inc and John Wiley & Sons Ltd.

Entities:  

Keywords:  Fox-Fordyce disease (FFD); Fractionated erbium glass laser; Surgical excision

Mesh:

Substances:

Year:  2016        PMID: 27072751      PMCID: PMC7949813          DOI: 10.1111/iwj.12586

Source DB:  PubMed          Journal:  Int Wound J        ISSN: 1742-4801            Impact factor:   3.315


  9 in total

1.  Apoeccrine sweat duct obstruction as a cause for Fox-Fordyce disease.

Authors:  Asako Kamada; Kenji Saga; Kowichi Jimbow
Journal:  J Am Acad Dermatol       Date:  2003-03       Impact factor: 11.527

2.  Fox-Fordyce disease treatment with fractional CO2 laser.

Authors:  Firas Ahmed Al-Qarqaz; Rasha Al-Shannag
Journal:  Int J Dermatol       Date:  2013-12       Impact factor: 2.736

3.  Consensus recommendations on the use of an erbium-doped 1,550-nm fractionated laser and its applications in dermatologic laser surgery.

Authors:  Michael Sherling; Paul M Friedman; Robert Adrian; A Jay Burns; Howard Conn; Richard Fitzpatrick; Richard Gregory; Suzanne Kilmer; Gary Lask; Vic Narurkar; Tracy M Katz; Mathew Avram
Journal:  Dermatol Surg       Date:  2010-02-19       Impact factor: 3.398

4.  Minimally Invasive Surgery for Axillary Osmidrosis Using a Combination of Subcutaneous Tissue Removal and a 1,444-nm Nd:YAG Laser.

Authors:  Sang Geun Lee; Hwa Jung Ryu; Il-Hwan Kim
Journal:  Ann Dermatol       Date:  2014-11-26       Impact factor: 1.444

5.  Treatment of active acne with an Er:Glass (1.54 microm) laser: a 2-year follow-up study.

Authors:  Sylvie Angel; Dominique Boineau; Serge Dahan; Serge Mordon
Journal:  J Cosmet Laser Ther       Date:  2006-12       Impact factor: 2.247

6.  Randomized split-face controlled study to evaluate 1550-nm fractionated erbium glass laser for treatment of acne vulgaris--an image analysis evaluation.

Authors:  Hoda Moneib; Abeer A Tawfik; Sahar S Youssef; Marwa M Fawzy
Journal:  Dermatol Surg       Date:  2014-11       Impact factor: 3.398

7.  Evaluation of the 1,540-nm Erbium:Glass Laser in the Treatment of Inflammatory Facial Acne.

Authors:  Melissa A Bogle; Jeffrey S Dover; Kenneth A Arndt; Serge Mordon
Journal:  Dermatol Surg       Date:  2007-07       Impact factor: 3.398

8.  Fox-Fordyce disease in a male patient--response to oral retinoid treatment.

Authors:  I Effendy; B Ossowski; R Happle
Journal:  Clin Exp Dermatol       Date:  1994-01       Impact factor: 3.470

9.  Extramammary paget disease: minimal surgical therapy.

Authors:  Ji-Hyun Choi; Mihn-Sook Jue; Eun-Jung Kim; Ok-Ja Joh; Kye-Yong Song; Hyang-Joon Park
Journal:  Ann Dermatol       Date:  2013-05-10       Impact factor: 1.444

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.